Pages that link to "Q30810332"
Jump to navigation
Jump to search
The following pages link to Selection for improved protein stability by phage display. (Q30810332):
Displaying 50 items.
- Structural Insights into the Evolution of a Non-Biological Protein: Importance of Surface Residues in Protein Fold Optimization (Q27644850) (← links)
- Somatic hypermutation maintains antibody thermodynamic stability during affinity maturation (Q27676628) (← links)
- Biotechnological applications of phage and cell display (Q28208441) (← links)
- Engineered single-domain antibodies with high protease resistance and thermal stability (Q28478199) (← links)
- Immunomodulation of cucumber mosaic virus infection by intrabodies selected in vitro from a stable single-framework phage display library. (Q30351050) (← links)
- In vitro rapid evolution of fungal immunomodulatory proteins by DNA family shuffling (Q30417072) (← links)
- Protein affinity maturation in vivo using E. coli mutator cells (Q30663254) (← links)
- Recombinant single-chain variable fragment antibodies directed against Clostridium difficile toxin B produced by use of an optimized phage display system (Q30782773) (← links)
- Protein stabilization through phage display (Q30888974) (← links)
- Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity (Q30923970) (← links)
- Antibodies in proteomics I: generating antibodies (Q30943792) (← links)
- Evolution of binding affinity in a WW domain probed by phage display (Q30980967) (← links)
- Identification of scFv antibody fragments that specifically recognise the heroin metabolite 6-monoacetylmorphine but not morphine (Q30981656) (← links)
- A "loop entropy reduction" phage-display selection for folded amino acid sequences (Q30984246) (← links)
- Evolutionary optimization of a nonbiological ATP binding protein for improved folding stability (Q31082717) (← links)
- Directed evolution of barnase stability using proteolytic selection (Q31113507) (← links)
- Biophysical properties of human antibody variable domains (Q31122335) (← links)
- Improved production and function of llama heavy chain antibody fragments by molecular evolution (Q31805030) (← links)
- Recombinant antibodies: a novel approach to cancer diagnosis and therapy (Q33181384) (← links)
- Genetic screens and directed evolution for protein solubility (Q33185813) (← links)
- Phage-display as a tool for quantifying protein stability determinants (Q33201959) (← links)
- An antibody library for stabilizing and crystallizing membrane proteins - selecting binders to the citrate carrier CitS. (Q33202365) (← links)
- Laboratory-directed protein evolution (Q33222949) (← links)
- Selecting and screening recombinant antibody libraries (Q33223036) (← links)
- Isolation of monomeric human V(H)s by a phage selection (Q33225080) (← links)
- Synthetic antibodies as therapeutics (Q33265617) (← links)
- Design of synthetic antibody libraries (Q33283622) (← links)
- New molecular reporters for rapid protein folding assays (Q33342837) (← links)
- High-throughput analysis of the protein sequence-stability landscape using a quantitative yeast surface two-hybrid system and fragment reconstitution (Q33357098) (← links)
- Thermostable llama single domain antibodies for detection of botulinum A neurotoxin complex (Q33378940) (← links)
- Bicistronic DNA display for in vitro selection of Fab fragments (Q33507484) (← links)
- Affinity maturation generates greatly improved xyloglucan-specific carbohydrate binding modules (Q33514131) (← links)
- Engineering of stable bispecific antibodies targeting IL-17A and IL-23. (Q33519833) (← links)
- Directed evolution of an anti-human red blood cell antibody (Q33523565) (← links)
- Progress in phage display: evolution of the technique and its application (Q33536051) (← links)
- A dual-targeting PDGFRbeta/VEGF-A molecule assembled from stable antibody fragments demonstrates anti-angiogenic activity in vitro and in vivo (Q33688219) (← links)
- Peptide phage display as a tool for drug discovery: targeting membrane receptors (Q33800879) (← links)
- High affinity, developability and functional size: the holy grail of combinatorial antibody library generation. (Q33888941) (← links)
- A protocol for phage display and affinity selection using recombinant protein baits (Q34014597) (← links)
- In vitro selection and evolution of proteins (Q34070107) (← links)
- An efficient method for variable region assembly in the construction of scFv phage display libraries using independent strand amplification (Q34301659) (← links)
- Synthetic antibodies: concepts, potential and practical considerations (Q34323205) (← links)
- Identification of Late Embryogenesis Abundant (LEA) protein putative interactors using phage display (Q34353727) (← links)
- Directed evolution of the forkhead-associated domain to generate anti-phosphospecific reagents by phage display (Q34417041) (← links)
- Antibody isolation from immunized animals: comparison of phage display and antibody discovery via V gene repertoire mining (Q34417503) (← links)
- Cloning, expression, purification, and characterization of LC-1 ScFv with GFP tag (Q34425553) (← links)
- Immunosensors--principles and applications to clinical chemistry (Q34445835) (← links)
- Antibody affinity maturation using yeast display with detergent-solubilized membrane proteins as antigen sources (Q34460171) (← links)
- Directed evolution of Her2/neu-binding IgG1-Fc for improved stability and resistance to aggregation by using yeast surface display (Q34522668) (← links)
- Frontier of therapeutic antibody discovery: The challenges and how to face them (Q34527769) (← links)